Published in Mol Cancer Res on May 26, 2015
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The hallmarks of cancer. Cell (2000) 113.05
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol (1992) 11.03
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene (2009) 8.01
A microRNA signature of hypoxia. Mol Cell Biol (2006) 7.24
Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science (1993) 4.64
The role of CXC chemokines and their receptors in cancer. Cancer Lett (2008) 3.84
Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics (1995) 3.60
Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am (1999) 2.85
MicroRNAs and the hallmarks of cancer. Oncogene (2006) 2.55
miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res (2012) 2.52
TGF-β upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest (2012) 2.44
AngiomiRs--key regulators of angiogenesis. Curr Opin Genet Dev (2009) 2.40
Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res (2004) 2.31
Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer (2008) 2.06
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun (2007) 1.96
Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma (2009) 1.88
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS One (2009) 1.72
Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal (2005) 1.65
MicroRNAs as therapeutic targets in cancer. Transl Res (2011) 1.64
Fighting cancer by attacking its blood supply. Sci Am (1996) 1.58
Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am (1998) 1.56
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer (2006) 1.54
Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res (2006) 1.49
Regulator of G-protein signaling (RGS) proteins in cancer biology. Biochem Pharmacol (2009) 1.31
Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis. J Surg Oncol (2003) 1.25
Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res (2004) 1.20
HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res (2001) 1.17
Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des (2009) 1.14
RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood (2005) 1.10
Evaluation and validation of housekeeping genes in response to ionizing radiation and chemical exposure for normalizing RNA expression in real-time PCR. Mutat Res (2007) 1.10
Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation. J Immunol (2003) 1.08
CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression. Mol Cancer (2010) 1.05
Synthesis of chondrocytic keratan sulphate-containing proteoglycans by human chondrosarcoma cells in long-term cell culture. J Bone Joint Surg Am (1991) 1.00
Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. J Cell Physiol (2009) 0.99
Angiogenic cytokines in cartilage tumors. Clin Orthop Relat Res (2002) 0.95
HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity. J Biol Chem (2009) 0.94
CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis. Mol Cancer Ther (2013) 0.94
Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours. J Bone Joint Surg Br (2008) 0.92
RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression. Tumour Biol (2010) 0.91
Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours. Histopathology (2010) 0.89
Alendronate inhibits growth of high-grade chondrosarcoma cells. Anticancer Res (2009) 0.89
Pathologic neovascularization in cartilage tumors. Clin Orthop Relat Res (2002) 0.89
MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells. Clin Orthop Relat Res (2015) 0.87
Characterization of CXCR4 expression in chondrosarcoma of bone. Arch Pathol Lab Med (2011) 0.83
Bystander effects induced by chemicals and ionizing radiation: evaluation of changes in gene expression of downstream MAPK targets. Mutagenesis (2010) 0.82